Head of the Group

Prof. Dr.-Ing. Udo Reichl
Prof. Dr.-Ing. Udo Reichl
Phone: +49 391 6110 201
Fax: +49 391 6110 203
Room: N0.19

Contact Person

Annegret Frauendienst
Phone:+49 391 6110-200Fax:+49 391 6110-203

Group Page

Publications

Publications BPE group

Talk (234)

  1. 501.
    Rapp, E.; Schwarzer, J.; Reichl, U.: Characterisation of Glycosylation Patterns Utilizing a DNA-Sequenzer and Mass Spectrometry. 14th European Carbohydrate Symposium, Lübeck, Germany (2007)
  2. 502.
    Reichl, U.: Theoretical and Experimental Characterization of Influenza Virus Replication in Cell Cultures. Meeting Helmholtz-Zentrum, Braunschweig, Germany (2007)
  3. 503.
    Reichl, U.: Theoretical and Experimental Characterization of Influenza Virus Replication in Cell Cultures. DECHEMA-Arbeitsausschuss Biotechnologie, Frankfurt/M., Germany (2007)
  4. 504.
    Reichl, U.: Mathematical Modeling of Mammalian Cell Cultures - Cell Growth and Product Synthesis. MPG-CNRS Treffen, Paris, France (2007)
  5. 505.
    Reichl, U.: MDCK cell derived influenza vaccines - aspects of up- and downstream processing. Meeting Merck & Co., Inc., USA (2007)
  6. 506.
    Reichl, U.: Mathematical Modeling of Mammalian Cell Cultures: From Cell Populations to Individual Cells. Workshop "Systems biology", Leipzig, Germany (2007)
  7. 507.
    Reichl, U.: A Systems Perspective of Virus Replication in Mammalian Cell Cultures. Meeting at MPI Golm, Potsdam-Golm, Germany (2007)
  8. 508.
    Reichl, U.: Influenza Vaccines: Challenges in Optimization of Virus Yields in Mammalian Cell Culture. Vaccine Congress, Amsterdam, The Netherlands (2007)
  9. 509.
    Reichl, U.: Characterization of Cell Growth and Influenza Virus Replication in Microcarrier Culture. Kooperationsgespräch bei ROCHE AG, Penzberg, Germany (2007)
  10. 510.
    Reichl, U.: A Systems Perspective of Influenza Virus Replication in Cell Cultures. European Conference on Complex Systems, Dresden, Germany (2007)
  11. 511.
    Ritter, J. B.; Genzel, Y.; Reichl, U.: Metabolite Analysis in Mammalian Cells: How to generate reliable data sets? 20th ESACT meeting, Dresden, Germany (2007)
  12. 512.
    Schmidt, J. K.; Riedele, C.; Regestein, L.; Geisler, L.; Reichl, U.: A Medically Relevant Three-Species Mixed Culture in a Chemostat: Mathematical Modelling and Experiments to Study Interaction Effects. European BioPerspectives 2007, Cologne, Germany (2007)
  13. 513.
    Schwarzer, J.; Rapp, E.; Reichl, U.: N-glycan analysis method for cell culture derived influenza virus hemagglutinin. Joint Meeting 2007, Lille, France (2007)
  14. 514.
    Genzel, Y.; Reichl, U.: Production of vaccines based on animal cell technology. Production of Biopharmaceuticals in Animal Cell Cultures, Rio de Janeiro, Brazil (2006)
  15. 515.
    Genzel, Y.; Schulze-Horsel, J.; Reichl, U.: High Cell Density Microcarrier Process in a Wave Bioreactor for the Production of Influenza A Virus. Vaccine Technology, Puerto Vallarta, Mexiko (2006)
  16. 516.
    Genzel, Y.; Reichl, U.: Limits and benefits of the interpretation of extracellular metabolite data in mammalian cell culture. 1st Max Planck Workshop on "Metabolomics", Magdeburg, Germany (2006)
  17. 517.
    Genzel, Y.; Kalbfuss, B.; Ritter, J. B.; Schulze-Horsel, J.; Rapp, E.; Vester, D.; Reichl, U.: Characterization and analytical issues on an influenza A virus production process. Vaccines : Quality control, scale-up and manufacture, Hamburg, Germany (2006)
  18. 518.
    Genzel, Y.; Sandig, V.; Jordan, I.: Neue Zellsubstrate und Einfluss von Medien und Prozessführung in der Impfstoffproduktion. 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
  19. 519.
    Kalbfuss, B.; Gedicke, K.; Seidel-Morgenstern, A.; Reichl, U.: Maximizing productivity in size-exclusion chromatography of influenza virus: A modelling approach. ESBES 6 : 6th European Symposium on Biochemical Engineering Science, Salzburg, Austria (2006)
  20. 520.
    Kalbfuss, B.; Wolff, M. W.; Genzel, Y.; Zimmermann, A.; Best, C.; Morenweiser, R.; Reichl, U.: A generic purification scheme for the production of human influenza vaccines derived from serum-free mammalian cell culture. Vaccine Technology, Puerto Vallarta, Mexico (2006)
  21. 521.
    Kalbfuss, B.; Wolff, M. W.; Genzel, Y.; Zimmermann, A.; Morenweiser, R.; Reichl, U.: Chromatography-based purification of influenza A virus for the production of human whole-virion vaccines. ISPPP 2006 : 26th International Symposium on the Separation of Proteins, Peptides and Polynucleotides, Innsbruck, Austria (2006)
  22. 522.
    Kalbfuss, B.; Wolff, M. W.; Geisler, L.; Thom, V.; Reichl, U.: Konzentrierung und Aufreinigung von Influenza Viren mittels Ionenaustauscher-Membranen. 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
  23. 523.
    Reichl, U.: Dynamics of Influenza Virus Replication in Mammalian Cell Culture. CCEX Workshop, Vancouver, Canada (2006)
  24. 524.
    Reichl, U.: MDCK Cell derived Influenza Vaccines: Aspects of Modeling and Experimental Design in Upstream Processing. Meeting at Sanof Pasteur, Toronto, Canada (2006)
  25. 525.
    Reichl, U.: Biological Fundamentals, Models and Technologies for Vaccine Production. Perspectives of Research - Identification and Implementation of Research Topics by Organizations : Ringberg-Symposium Mai 2006, Kreuth, Germany (2006)
  26. 526.
    Reichl, U.: Mathematical Models for Mammalian Cell Growth and Virus Replication for an Influenza Vaccine Production Process. Technische Universität Berlin : Meeting, Berlin, Germany (2006)
  27. 527.
    Reichl, U.: MDCK Cell Derived Influenza Vaccines: Aspects of Up- and Downstream Processing. Meeting Academy of Science, Sofia, Bulgarien (2006)
  28. 528.
    Ritter, J. B.; Genzel, Y.; Reichl, U.: Monitoring Energy Metabolism: The Challenge of Intracellular Metabolite Analysis of Mammalian Cells in Culture. 1st Max Planck Workshop on "Metabolomics", Magdeburg, Germany (2006)
  29. 529.
    Schulze-Horsel, J.; Bock, A.; Genzel, Y.; Reichl, U.: Mammalian cell culture for influenza vaccine production: physiology during cell growth and virus propagation phase. GVC/DECHEMA-Jahrestagungen 2006 mit 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
  30. 530.
    Wahl, A.; Nöh, K.; Wiechert, W.: Metabolic and Isotopic Instationary Experiments: A Simulative Study. Metabolic Engineering VI, Noordwijkerhout, The Netherlands (2006)
  31. 531.
    Wahl, S. A.; Nöh, K.; Wiechert, W.: Experiments at Metabolic and Isotopic Instationary State: An Exploratory study. Metabolic Engineering VI : From recDNA Towards Engineering Biological Systems, Noordwijkerhout, Netherlands (2006)
  32. 532.
    Wolff, M. W.; Kalbfuss, B.; Opitz, L.; Zimmermann, A.; Lehmann, S.; Reichl, U.: Downstream Process of Influenza Viruses. European BioPharm Scale-Up Congress 2006, Geneva, Switzerland (2006)
  33. 533.
    Wolff, M. W.; Kalbfuss, B.; Lehmann, S.; Morenweiser, R.; Opitz, L.; Zimmermann, A.; Reichl, U.: Downstream Processes and Glycan Characterization of MDCK-Cell Derived Influenza Virus. BioProcess Technology - Asia, Singapore (2006)
  34. 534.
    Genzel, Y.; Schulze-Horsel, J.; Möhler, L.; Sidorenko, Y.; Reichl, U.: Influenza Vaccines: Challenges in Mammalian Cell Culture Technology. 19th ESACT Meeting, Harrogate, UK (2005)
  35. 535.
    Heßeler, J.; Schmidt, J. K.; Reichl, U.; Flockerzi, D.: How to achieve coexistence in the chemostat: a combined mathematical and experimental approach. European Conference on Mathematical and Theoretical Biology (ECMTB), Dresden, Germany (2005)
  36. 536.
    Wolff, M.; Kalbfuss, B.; Morenweiser, R.; Zimmermann, A.; Reichl, U.: Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion Vaccines. Viral Vectors and Vaccines Conference, Austin, Texas (2005)
  37. 537.
    Wolff, M. W.; Salaklang, J.; Opitz, L.; Schwarzer, J.; Rapp, E.; Kalbfuss, B.; Reichl, U.: Development of a lectin-affinity chromatography step for the downstream processing of influenza virus vaccines. AICHE Annual Meeting 2005, Cincinnati, Ohio, USA (2005)
  38. 538.
    Genzel, Y.; König, S.; Reichl, U.: Amino acid analysis in mammalian cell culture based virus vaccine production processes. IICS : 17th annual International Ion Chromatography Symposium, Trier, Germany (2004)
  39. 539.
    Rapp, E.; Lubda, D.; Seidel-Morgenstern, A.; Reichl, U.; Tallarek, U.: Sheathless ESI-Interface for Coupling Capillary Separation Techniques to Mass Spectromety. 37. Diskussionstagung der Deutschen Gesellschaft für Massenspektrometrie, Leipzig, Germany (2004)

Poster (301)

  1. 540.
    Behne, A.; Bock, A.; Hennig, R.; Reichl, U.; Rapp, E.: Characterizing the Sweet Sites of Therapeutic Glycoproteins using glyXbox. Congress: „new and emerging technologies“, Potsdam, Germany (2017)
  2. 541.
    Bergmann, C.; Schildbach, A.; Rexer, T.; Rapp, E.; Reichl, U.; Pietzsch, M.: In-vitro synthesis of a phytanyl-pyrophosphate-linked oligosaccharide by a cascade of Alg2 and Alg11 as part of a platform for N-glycosylation of therapeutic proteins. GlycoBioTec Symposium 2017, Berlin, Germany (2017)
  3. 542.
    Bissinger, T.; Rodrigues Correia Ramos, J.; Ringeisen, J.; Genzel, Y.; Reichl, U.: Intracellular Metabolic Pool Dynamics in MDCK Suspension Cells during Growth and Influenza Virus Infection. 25th ESACT Meeting, Lausanne, Switzerland (2017)
  4. 543.
    Fortuna, A. R.; Tamargo Granados, L.; Gasczyk, C.; Grundke, S.; Toeppner, K.; Hundt, B.; Schleuss, T.; Villain, L.; Wolff, M. W.; Reichl, U.: Tangential flow filtration of influenza virus feed streams for veterinary vaccine production. ICOM 2017: International Congress on Membranes and Membrane Processes, San Francisco, USA (2017)
  5. 544.
    Hennig, R.; Bock, A.; Behne, A.; Reichl, U.; Rapp, E.: The glyXtoolTM software suite - introducing the next generation of automated high-throughput glycoprofiling. Congress: „new and emerging technologies“, Potsdm, Germany (2017)
  6. 545.
    Hoffmann, M.; Bartels, M.F.; Hennig, R.; Pioch, M.; Reichl, U.; Strahl, S.; Rapp, E.: Unravelling the Interplay between Protein O-Mannosylation and N-Glycosylation-An N-Glycomic and N-Glycoproteomic Study of Human N-Cadherin. DFG FOR 2509 Kick-off Meeting, Heidleberg, Germany (2017)
  7. 546.
    Hoffmann, M.: Unravelling the Correlation between Different ER-Based Types of Glycosylation via Glyco/Proteo-Analytics. DFG FOR 2509 Kick-off meeting, Heidelberg, Germany (2017)
  8. 547.
    Hoffmann, M.; Pioch, M.; Pralow, A.; Nguyen-Khuong, T.; Hennig, R.; Kottler, R.; Reichl, U.; Rapp, E.: Site-Specific N-and O-Glycoproteomic Analysis Using Stepped Collisional Energy Fragmentation on a Linear Iontrap/ Orbitrap Hybrid Mass Spectrometer. GlycoBioTec Symposium 2017, Berlin, Germany (2017)
  9. 548.
    Koch, S.; Benndorf, D.; Kohrs, F.; Lahmann, P.; Reichl, U.; Klamt, S.: Strategies for Modeling of Large-Scale Metabolic Models of Microbial Communities. Metabolic Pathway Analysis 2017, Bozeman, Montana, USA (2017)
  10. 549.
    Kohrs, F.; Heyer, R.; Bissinger, T.; Kottler, R.; Schallert, K.; Püttker, S.; Behne, A.; Rapp, E.; Benndorf, D.; Reichl, U.: Proteotyping of microbial communities from laboratory-scale biogas plants reveals multiple steady-states. 14th Symposium on Bacterial Genetics and Ecology (BAGECO 14), Aberdeen, Scotland (2017)
  11. 550.
    Mahour, R.; Klapproth, J.; Rexer, T.; Schildbach, A.; Pietzsch, M.; Rapp, E.; Reichl, U.: In vitro multienzymatic network for production of UDP-GlcNAc. DECHEMA Summer School 2017: Biotransformations 2017, Hannover, Germany (2017)
 
Go to Editor View
loading content